Affordable Access

The use of antithymocyte globulin in myasthenia gravis.

Authors
Type
Published Article
Journal
Postgraduate medical journal
Publication Date
Volume
52
Issue
5 Suppl
Pages
110–111
Identifiers
PMID: 1087016
Source
Medline

Abstract

Antithymocyte globulin (ATG) has been used to treat three female patients with myastenia gravis. No other immunosuppressive agent was used. All three cases responded favourably to ATG therapy. This suggest that further work should be undertaken in this field though the condition itself is extremely variable and this study was not controlled.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments